Clinical trial
Directly Observed Therapy in High Risk Populations in Newark, NJ
NCT00285883 · Saint Michael's Medical Center, Other · Completed
Key facts
| NCT number | NCT00285883 |
|---|---|
| Title | Directly Observed Therapy in High Risk Populations in Newark, NJ |
| Official title | Directly Observed Therapy in High Risk Populations in Newark, NJ |
| Lead sponsor | Saint Michael's Medical Center, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Directly Observed Therapy, HIV Infections |
| Intervention type | Drug |
| Interventions | Invirase, Norvir |
| Enrollment | 30 |
| Start date | Apr 1, 2004 |
| Completion | May 1, 2006 |
| First posted | Feb 2, 2006 |
| Last update posted | Feb 28, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: